NEW YORK (GenomeWeb News) – Accelrys today posted a 7-percent decline in revenues for its second fiscal quarter, alongside a 19-percent decrease in net income.
 
Revenue for the quarter ended Sept. 30 declined to $20.2 million from $21.7 million in the second quarter of 2005. The company attributed the slide to “an expected decrease in revenues from certain products that were de-emphasized in connection with the company's restructuring and product line adjustments that have occurred over the past two years.”
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.